(PCRB) Putnam Trust - Putnam ESG - Ratings and Ratios
Bonds, ESG, Investment-Grade, Fixed-Income
Dividends
| Dividend Yield | 4.29% |
| Yield on Cost 5y | 4.80% |
| Yield CAGR 5y | 16.97% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 3.17% |
| Value at Risk 5%th | 5.28% |
| Relative Tail Risk | 1.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.43 |
| Alpha | 1.92 |
| CAGR/Max DD | 0.54 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.362 |
| Beta | 0.020 |
| Beta Downside | -0.009 |
| Drawdowns 3y | |
|---|---|
| Max DD | 7.20% |
| Mean DD | 1.74% |
| Median DD | 1.48% |
Description: PCRB Putnam Trust - Putnam ESG November 30, 2025
The Putnam ESG Core Bond ETF (ticker PCRB) is a U.S.-based, intermediate-core bond fund that invests primarily in a diversified basket of investment-grade fixed-income securities. Its manager, Putnam Management, selects issuers that satisfy sector-specific environmental, social, or governance (ESG) criteria, aiming to blend credit quality with sustainable investing standards.
Key metrics (as of the latest public filing) include an expense ratio of roughly 0.25 %, a weighted-average maturity of about 7 years, and a portfolio duration near 5 years, positioning the fund to be moderately sensitive to interest-rate moves. The fund’s average credit rating hovers around A-, reflecting a focus on high-quality issuers. Current macro drivers-namely the Federal Reserve’s policy stance on rates, inflation trends, and the growing demand for ESG-aligned capital-are likely to influence both yield levels and inflows into the ETF.
For a deeper dive into how PCRB’s ESG screening compares with peers and to explore its risk-adjusted performance, you might find ValueRay’s analytical tools useful.
What is the price of PCRB shares?
Over the past week, the price has changed by +0.05%, over one month by +0.43%, over three months by +0.51% and over the past year by +6.23%.
Is PCRB a buy, sell or hold?
What are the forecasts/targets for the PCRB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 53.4 | 7.9% |
PCRB Fundamental Data Overview December 16, 2025
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 868.4m USD (868.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 868.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 868.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.09% (E(868.4m)/V(868.4m) * Re(6.09%) + (debt-free company))
Discount Rate = 6.09% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for PCRB ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle